AIDS in Canada—Supplementary tables, 2016
Volume 43-12, December 7, 2017: Can we eliminate HIV?
Web exclusive
AIDS in Canada—Supplementary tables, 2016
L Jonah1, AC Bourgeois1, M Edmunds1, A Awan1, O Varsaneux1, W Siu1
Affiliation
1 Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON
Correspondence
Suggested citation
L Jonah, AC Bourgeois, M Edmunds, A Awan, O Varsaneux, W Siu. AIDS in Canada – Supplementary tables, 2016. Can Commun Dis Rep. 2017;43(12). Web exclusive. https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-12-december-7-2017/aids-2016-supplementary-tables.html
This article provides supplementary data for the surveillance report in this issue entitled: AIDS in Canada—Surveillance Report, 2016Footnote 1
Submit a manuscript
About CCDR
Browse
Province/territory | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | % | |
British ColumbiaTable 1 - Footnote * | |||||||||||||
Males | 4,192 | 111 | 109 | 87 | 80 | 74 | 60 | 50 | 57 | 59 | NR | 4,879 | 29.6 |
Females | 405 | 21 | 34 | 24 | 26 | 12 | 11 | 16 | 13 | 13 | NR | 575 | 28.2 |
Total | 4,701 | 141 | 147 | 125 | 116 | 98 | 83 | 82 | 86 | 73 | NR | 5,652 | 23.4 |
Yukon | |||||||||||||
Males | 4 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 8 | 0 |
Females | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0.2 |
Total | 8 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 13 | 0.1 |
Alberta | |||||||||||||
Males | 1,196 | 49 | 52 | 31 | 30 | 26 | 34 | 21 | 25 | 8 | 13 | 1,485 | 9 |
Females | 113 | 11 | 9 | 7 | 4 | 6 | 8 | 11 | 9 | 8 | 6 | 192 | 9.4 |
Total | 1,309 | 60 | 61 | 38 | 34 | 32 | 42 | 32 | 34 | 16 | 19 | 1,677 | 9.1 |
Northwest Territories | |||||||||||||
Males | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 16 | 0.1 |
Females | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0.2 |
Total | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 21 | 0.1 |
NunavutTable 1 - Footnote † | |||||||||||||
Males | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Females | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Saskatchewan | |||||||||||||
Males | 192 | 6 | 7 | 7 | 24 | 17 | 23 | 16 | 24 | 15 | 12 | 343 | 2.1 |
Females | 41 | 3 | 6 | 7 | 4 | 10 | 13 | 11 | 9 | 14 | 10 | 128 | 6.3 |
Total | 233 | 9 | 13 | 14 | 28 | 27 | 36 | 27 | 33 | 29 | 22 | 471 | 2.5 |
Manitoba | |||||||||||||
Males | 222 | 4 | 5 | 3 | 2 | 2 | 5 | 2 | 0 | 4 | 1 | 250 | 1.5 |
Females | 40 | 4 | 1 | 0 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 50 | 2.4 |
Total | 262 | 8 | 6 | 3 | 4 | 3 | 7 | 2 | 0 | 4 | 1 | 300 | 1.6 |
Ontario | |||||||||||||
Males | 7,505 | 142 | 140 | 103 | 107 | 101 | 70 | 85 | 57 | 54 | 54 | 8,418 | 51.1 |
Females | 675 | 24 | 41 | 24 | 18 | 19 | 8 | 20 | 13 | 9 | 12 | 863 | 42.3 |
Total | 8,182 | 167 | 181 | 127 | 125 | 120 | 79 | 106 | 70 | 63 | 66 | 9,286 | 50.1 |
QuebecTable 1 - Footnote ‡ | |||||||||||||
Males | 5,373 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 5,373 | 32.6 |
Females | 725 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 725 | 35.5 |
Total | 6,098 | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 6,098 | 32.9 |
New Brunswick | |||||||||||||
Males | 152 | 3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 167 | 1 |
Females | 18 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 22 | 1.1 |
Total | 170 | 4 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 4 | 189 | 1 |
Nova Scotia | |||||||||||||
Males | 300 | 3 | 5 | 2 | 5 | 3 | 3 | 0 | 4 | 3 | 1 | 329 | 2 |
Females | 27 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31 | 1.5 |
Total | 327 | 5 | 6 | 2 | 5 | 4 | 3 | 0 | 4 | 3 | 1 | 360 | 1.9 |
Prince Edward IslandTable 1 - Footnote § | |||||||||||||
Males | 19 | 0 | 0 | 0 | 0 | 0 | 1 | NR | NR | NR | NR | 20 | 0.1 |
Females | 1 | 0 | 0 | 0 | 0 | 0 | 0 | NR | NR | NR | NR | 1 | 0 |
Total | 20 | 0 | 0 | 0 | 0 | 0 | 1 | NR | NR | NR | NR | 21 | 0.1 |
Newfoundland and LabradorTable 1 - Footnote ¶ | |||||||||||||
Males | 71 | 0 | 0 | NR | NR | NR | NR | NR | NR | NR | NR | 71 | 0.4 |
Females | 20 | 0 | 0 | NR | NR | NR | NR | NR | NR | NR | NR | 20 | 1 |
Total | 91 | 0 | 0 | NR | NR | NR | NR | NR | NR | NR | NR | 91 | 0.5 |
Grand Total | 16,719 | 253 | 268 | 187 | 199 | 187 | 170 | 169 | 144 | 117 | 114 | 18,527 | 100 |
Grand total males | 15,048 | 207 | 210 | 148 | 171 | 150 | 138 | 126 | 113 | 86 | 83 | 16,480 | 100 |
Grand total females | 1,669 | 45 | 58 | 39 | 28 | 37 | 31 | 42 | 31 | 31 | 31 | 2,042 | 100 |
Age and sex | Number of cases reported | %Table 1 - Footnote ¶ |
---|---|---|
Children (<15 years) | ||
Males | 117 | 53.2 |
Females | 103 | 46.8 |
Sex not reported/transsexual/transgender | 0 | n/a |
Total | 220 | 1.2 |
Adults (≥15 years) | ||
Males | 16,362 | 89.4 |
Females | 1,938 | 10.6 |
Sex not reported/transsexual/transgender | 5 | n/a |
Total | 18,305 | 98.8 |
Age group not reported | ||
Males | 1 | 50 |
Females | 1 | 50 |
Sex not reported/transsexual/transgender | 0 | n/a |
Total | 2 | n/a |
Grand Total | 18,527 | n/a |
Males | 16,480 | 89 |
Females | 2,042 | 11 |
Sex not reported/transsexual/transgender | 5 | n/a |
Year of diagnosis | Males | Females | Sex not reported/transsexual/transgender | Total | ||||
---|---|---|---|---|---|---|---|---|
No. of cases | Cumulative total | No. of cases | Cumulative total | No. of cases | Cumulative total | No. of cases | Cumulative total | |
1979-2006 | 15,048 | 15,048 | 1,669 | 1,669 | 2 | 2 | 16,719 | 16,719 |
2007 | 207 | 15,255 | 45 | 1,714 | 1 | 3 | 253 | 16,972 |
2008 | 210 | 15,465 | 58 | 1,772 | 0 | 3 | 268 | 17,240 |
2009 | 148 | 15,613 | 39 | 1,811 | 0 | 3 | 187 | 17,427 |
2010 | 171 | 15,784 | 28 | 1,839 | 0 | 3 | 199 | 17,626 |
2011 | 150 | 15,934 | 37 | 1,876 | 0 | 3 | 187 | 17,813 |
2012 | 138 | 16,072 | 31 | 1,907 | 1 | 4 | 170 | 17,983 |
2013 | 126 | 16,198 | 42 | 1,949 | 1 | 5 | 169 | 18,152 |
2014 | 113 | 16,311 | 31 | 1,980 | 0 | 5 | 144 | 18,296 |
2015 | 86 | 16,397 | 31 | 2,011 | 0 | 5 | 117 | 18,413 |
2016 | 83 | 16,480 | 31 | 2,042 | 0 | 5 | 114 | 18,527 |
Total | 16,480 | n/a | 2,042 | n/a | 5 | n/a | 18,527 | n/a |
Cohort | Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 4 - Footnote ¶ | ||
Children | <1 year | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 94 | 0.5 |
1 to 4 years | 61 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63 | 0.3 | |
5 to 9 years | 30 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 32 | 0.2 | |
10 to 14 years | 29 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 31 | 0.2 | |
Total | 212 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 220 | 1.2 | |
Adults | 15 to 19 years | 60 | 1 | 1 | 3 | 2 | 4 | 2 | 2 | 1 | 2 | 3 | 81 | 0.4 |
20 to 24 years | 541 | 3 | 10 | 4 | 4 | 6 | 6 | 2 | 6 | 5 | 4 | 591 | 3.2 | |
25 to 29 years | 2,157 | 16 | 12 | 6 | 14 | 8 | 6 | 19 | 11 | 9 | 11 | 2,269 | 12.2 | |
30 to 34 years | 3,644 | 24 | 30 | 26 | 16 | 16 | 24 | 19 | 21 | 17 | 13 | 3,850 | 20.8 | |
35 to 39 years | 3,555 | 40 | 52 | 30 | 28 | 29 | 27 | 20 | 17 | 15 | 14 | 3,827 | 20.7 | |
40 to 44 years | 2,790 | 62 | 47 | 37 | 38 | 40 | 26 | 24 | 16 | 11 | 14 | 3,105 | 16.8 | |
45 to 49 years | 1,739 | 39 | 53 | 46 | 42 | 34 | 30 | 36 | 29 | 22 | 13 | 2,083 | 11.2 | |
50 to 54 years | 925 | 32 | 35 | 11 | 25 | 21 | 23 | 19 | 13 | 16 | 16 | 1,136 | 6.1 | |
55 to 59 years | 562 | 16 | 12 | 13 | 13 | 13 | 11 | 10 | 14 | 8 | 13 | 685 | 3.7 | |
≥60 years | 534 | 17 | 15 | 10 | 17 | 16 | 14 | 17 | 14 | 12 | 12 | 678 | 3.7 | |
Total | 16,507 | 250 | 267 | 186 | 199 | 187 | 169 | 168 | 142 | 117 | 113 | 18,305 | 98.8 | |
Subtotal | 16,719 | 252 | 268 | 187 | 199 | 187 | 170 | 169 | 143 | 117 | 114 | 18,525 | n/a | |
Age group not reported | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | n/a | |
Total | 16,719 | 253 | 268 | 187 | 199 | 187 | 170 | 169 | 144 | 117 | 114 | 18,527 | n/a | |
Cohort | Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 5 - Footnote ¶ | ||
Male children | <1 year | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 44 | 0.3 |
1 to 4 years | 25 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0.2 | |
5 to 9 years | 21 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 22 | 0.1 | |
10 to 14 years | 23 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 0.1 | |
Total | 112 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 117 | 0.7 | |
Adult males | 15 to 19 years | 45 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 3 | 54 | 0.3 |
20 to 24 years | 432 | 2 | 7 | 3 | 2 | 2 | 2 | 1 | 5 | 4 | 2 | 462 | 2.8 | |
25 to 29 years | 1,874 | 8 | 9 | 3 | 12 | 6 | 5 | 13 | 6 | 4 | 7 | 1,947 | 11.8 | |
30 to 34 years | 3,274 | 14 | 19 | 16 | 15 | 9 | 17 | 14 | 15 | 8 | 9 | 3,410 | 20.7 | |
35 to 39 years | 3,295 | 31 | 37 | 26 | 21 | 23 | 21 | 14 | 10 | 9 | 11 | 3,498 | 21.2 | |
40 to 44 years | 2,585 | 53 | 40 | 27 | 35 | 34 | 22 | 17 | 11 | 10 | 10 | 2,844 | 17.3 | |
45 to 49 years | 1,630 | 38 | 44 | 40 | 38 | 30 | 26 | 28 | 27 | 17 | 9 | 1,927 | 11.7 | |
50 to 54 years | 863 | 28 | 29 | 10 | 22 | 20 | 19 | 15 | 11 | 14 | 12 | 1,043 | 6.3 | |
55 to 59 years | 496 | 14 | 11 | 13 | 12 | 10 | 11 | 8 | 13 | 7 | 9 | 604 | 3.7 | |
≥60 years | 442 | 16 | 14 | 8 | 14 | 15 | 13 | 15 | 14 | 12 | 10 | 573 | 3.5 | |
Total | 14,936 | 204 | 210 | 147 | 171 | 150 | 137 | 126 | 113 | 86 | 82 | 16,362 | 99.3 | |
Subtotal | 15,048 | 206 | 210 | 148 | 171 | 150 | 138 | 126 | 113 | 86 | 83 | 16,479 | n/a | |
Age group not reported | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | n/a | |
TotalTable 5 - Footnote ‖ | 15,048 | 207 | 210 | 148 | 171 | 150 | 138 | 126 | 113 | 86 | 83 | 16,480 | n/a | |
Cohort | Age group | Year of diagnosis | Total | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 6 - Footnote ¶ | ||
Female children | <1 year | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 50 | 2.4 |
1 to 4 years | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36 | 1.8 | |
5 to 9 years | 9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0.5 | |
10 to 14 years | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 7 | 0.3 | |
Total | 100 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 103 | 5 | |
Adult females | 15 to 19 years | 15 | 1 | 1 | 2 | 2 | 3 | 1 | 1 | 0 | 1 | 0 | 27 | 1.3 |
20 to 24 years | 109 | 1 | 3 | 1 | 2 | 4 | 4 | 1 | 1 | 1 | 2 | 129 | 6.3 | |
25 to 29 years | 283 | 8 | 3 | 3 | 2 | 2 | 1 | 5 | 5 | 5 | 4 | 321 | 15.7 | |
30 to 34 years | 369 | 9 | 11 | 10 | 1 | 7 | 7 | 5 | 6 | 9 | 4 | 438 | 21.5 | |
35 to 39 years | 260 | 9 | 15 | 4 | 7 | 6 | 5 | 6 | 7 | 6 | 3 | 328 | 16.1 | |
40 to 44 years | 205 | 9 | 7 | 10 | 3 | 6 | 4 | 7 | 5 | 1 | 4 | 261 | 12.8 | |
45 to 49 years | 109 | 1 | 9 | 6 | 4 | 4 | 4 | 8 | 2 | 5 | 4 | 156 | 7.6 | |
50 to 54 years | 62 | 4 | 6 | 1 | 3 | 1 | 4 | 4 | 2 | 2 | 4 | 93 | 4.6 | |
55 to 59 years | 65 | 2 | 1 | 0 | 1 | 3 | 0 | 2 | 1 | 1 | 4 | 80 | 3.9 | |
≥60 years | 92 | 1 | 1 | 2 | 3 | 1 | 1 | 2 | 0 | 0 | 2 | 105 | 5.1 | |
Total | 1,569 | 45 | 57 | 39 | 28 | 37 | 31 | 41 | 29 | 31 | 31 | 1,938 | 95 | |
Subtotal | 1,669 | 45 | 58 | 39 | 28 | 37 | 31 | 42 | 30 | 31 | 31 | 2,041 | n/a | |
Age group not reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | n/a | |
TotalTable 6 - Footnote ‖ | 1,669 | 45 | 58 | 39 | 28 | 37 | 31 | 42 | 31 | 31 | 31 | 2,042 | n/a | |
Exposure category | Sub-exposure category | Year of diagnosis | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 7 - Footnote ¶ | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
MSM | n/a | 10,787 | 68 | 19 | 22.9 | 14 | 23.3 | 14 | 19.7 | 9 | 18 | 7 | 17.5 | 10,850 | 67.1 |
MSM/IDU | n/a | 656 | 4.1 | 1 | 1.2 | 1 | 1.7 | 2 | 2.8 | 0 | 0 | 1 | 2.5 | 661 | 4.1 |
IDU | n/a | 1,173 | 7.4 | 29 | 34.9 | 21 | 35 | 22 | 31 | 22 | 44 | 14 | 35 | 1,281 | 7.9 |
Blood/blood products | Recipient of blood/clotting factor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Recipient of blood | 287 | 1.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 287 | 1.8 | |
Recipient of clotting factor | 233 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 233 | 1.4 | |
Heterosexual contact | Origin from an HIV-endemic country | 1,234 | 7.8 | 6 | 7.2 | 3 | 5 | 4 | 5.6 | 4 | 8 | 3 | 7.5 | 1,254 | 7.8 |
Sexual contact with a person at risk | 898 | 5.7 | 13 | 15.7 | 13 | 21.7 | 10 | 14.1 | 6 | 12 | 8 | 20 | 948 | 5.9 | |
NIR-Het | 592 | 3.7 | 13 | 15.7 | 8 | 13.3 | 15 | 21.1 | 6 | 12 | 7 | 17.5 | 641 | 4 | |
Perinatal transmission | n/a | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Occupational exposure | n/a | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 8 | 0 |
Other | n/a | 4 | 0 | 2 | 2.4 | 0 | 0 | 4 | 5.6 | 2 | 4 | 0 | 0 | 12 | 0.1 |
Subtotal | n/a | 15,872 | - | 83 | - | 60 | - | 71 | - | 50 | - | 40 | - | 16,176 | - |
NIR | n/a | 551 | - | 2 | - | 0 | - | 0 | - | 3 | - | 3 | - | 559 | - |
Not reportedTable 7 - Footnote ‖ | n/a | 1173 | - | 84 | - | 108 | - | 71 | - | 64 | - | 70 | - | 1,570 | - |
Total | n/a | 17,596 | - | 169 | - | 168 | - | 142 | - | 117 | - | 113 | - | 18,305 | - |
Exposure category | Sub-exposure category | Year of diagnosis | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 8 - Footnote ¶ | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
MSM | n/a | 10,787 | 75.1 | 19 | 30.6 | 14 | 34.1 | 14 | 25.5 | 9 | 31 | 7 | 29.2 | 10,850 | 74.5 |
MSM/IDU | n/a | 656 | 4.6 | 1 | 1.6 | 1 | 2.4 | 2 | 3.6 | 0 | 0 | 1 | 4.2 | 661 | 4.5 |
IDU | n/a | 852 | 5.9 | 18 | 29 | 13 | 31.7 | 14 | 25.5 | 8 | 27.6 | 6 | 25 | 911 | 6.3 |
Blood/blood products | Recipient of blood/clotting factor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Recipient of blood | 172 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 172 | 1.2 | |
Recipient of clotting factor | 223 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 223 | 1.5 | |
Heterosexual contact | Origin from an HIV-endemic country | 758 | 5.3 | 4 | 6.5 | 1 | 2.4 | 3 | 5.5 | 2 | 6.9 | 1 | 4.2 | 769 | 5.3 |
Sexual contact with a person at risk | 462 | 3.2 | 7 | 11.3 | 7 | 17.1 | 8 | 14.5 | 3 | 10.3 | 5 | 20.8 | 492 | 3.4 | |
NIR-Het | 438 | 3.1 | 12 | 19.4 | 5 | 12.2 | 11 | 20 | 5 | 17.2 | 4 | 16.7 | 475 | 3.3 | |
Perinatal transmission | n/a | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Occupational exposure | n/a | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3.4 | 0 | 0 | 6 | 0 |
Other | n/a | 3 | 0 | 1 | 1.6 | 0 | 0 | 3 | 5.5 | 1 | 3.4 | 0 | 0 | 8 | 0.1 |
Subtotal | n/a | 14,357 | - | 62 | - | 41 | - | 55 | - | 29 | - | 24 | - | 14,568 | - |
NIR | n/a | 501 | - | 1 | - | 0 | - | 0 | - | 2 | - | 2 | 506 | - | |
Not reportedTable 8 - Footnote ‖ | n/a | 960 | - | 74 | - | 85 | - | 58 | - | 55 | - | 56 | 1,288 | - | |
TotalTable 8 - Footnote ** | n/a | 15,818 | - | 137 | - | 126 | - | 113 | - | 86 | - | 82 | 16,362 | - | |
Exposure category | Sub-exposure category | Year of diagnosis | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Table 9 - Footnote ¶ | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
IDU | n/a | 321 | 21.2 | 11 | 52.4 | 8 | 42.1 | 8 | 50 | 14 | 66.7 | 8 | 50 | 370 | 23 |
Blood/blood products | Recipient of blood/clotting factor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Recipient of blood | 115 | 7.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115 | 7.2 | |
Recipient of clotting factor | 10 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0.6 | |
Heterosexual contact | Origin from an HIV-endemic country | 476 | 31.4 | 2 | 9.5 | 2 | 10.5 | 1 | 6.3 | 2 | 9.5 | 2 | 12.5 | 485 | 30.2 |
Sexual contact with a person at risk | 436 | 28.8 | 6 | 28.6 | 6 | 31.6 | 2 | 12.5 | 3 | 14.3 | 3 | 18.8 | 456 | 28.4 | |
NIR-Het | 154 | 10.2 | 1 | 4.8 | 3 | 15.8 | 4 | 25 | 1 | 4.8 | 3 | 18.8 | 166 | 10.3 | |
Occupational exposure | n/a | 2 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0.1 |
Other | n/a | 1 | 0.1 | 1 | 4.8 | 0 | 0 | 1 | 6.3 | 1 | 4.8 | 0 | 0 | 4 | 0.2 |
Subtotal | n/a | 1,515 | - | 21 | - | 19 | - | 16 | - | 21 | - | 16 | - | 1,608 | - |
NIR | n/a | 49 | - | 1 | - | 0 | - | 0 | - | 1 | - | 1 | - | 52 | - |
Not reportedTable 9 - Footnote ‖ | n/a | 211 | - | 9 | - | 22 | - | 13 | - | 9 | - | 14 | - | 278 | - |
TotalTable 9 - Footnote ** | n/a | 1,775 | - | 31 | - | 41 | - | 29 | - | 31 | - | 31 | - | 1,938 | - |
Exposure category | Exposure sub-category | Age group (years) | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
15-19 | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | ≥60 | |||
MSM | n/a | 9 | 255 | 1,360 | 2,409 | 2,474 | 1,930 | 1,230 | 608 | 327 | 248 | 10,850 |
MSM/IDU | n/a | 4 | 48 | 134 | 184 | 127 | 79 | 47 | 19 | 16 | 3 | 661 |
IDU | n/a | 12 | 71 | 166 | 303 | 301 | 222 | 118 | 55 | 25 | 8 | 1,281 |
Blood/blood products | Recipient of blood/clotting factor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Recipient of blood | 4 | 13 | 19 | 34 | 35 | 28 | 26 | 25 | 31 | 72 | 287 | |
Recipient of clotting factor | 22 | 20 | 42 | 37 | 37 | 24 | 18 | 13 | 10 | 10 | 233 | |
Heterosexual contact | Origin from an HIV-endemic country | 3 | 54 | 198 | 310 | 272 | 202 | 98 | 54 | 20 | 43 | 1,254 |
Sexual contact with a person at risk | 4 | 42 | 121 | 170 | 139 | 141 | 120 | 75 | 65 | 71 | 948 | |
NIR-Het | 1 | 26 | 64 | 110 | 87 | 99 | 76 | 68 | 50 | 60 | 641 | |
Perinatal transmission | n/a | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Occupational exposure | n/a | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 2 | 1 | 1 | 8 |
Other | n/a | 1 | 0 | 0 | 1 | 2 | 3 | 1 | 2 | 1 | 1 | 12 |
Subtotal | n/a | 61 | 529 | 2,104 | 3,558 | 3,476 | 2,730 | 1,734 | 921 | 546 | 517 | 16,176 |
NIR | n/a | 4 | 22 | 68 | 96 | 109 | 85 | 63 | 48 | 28 | 36 | 559 |
Not reportedTable 10 - Footnote ¶ | n/a | 16 | 40 | 97 | 196 | 242 | 290 | 286 | 167 | 111 | 125 | 1,570 |
Total | n/a | 81 | 591 | 2,269 | 3,850 | 3,827 | 3,105 | 2,083 | 1,136 | 685 | 678 | 18,305 |
Exposure category | Exposure sub-category | Province/territory | Total | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BCTable 11 - Footnote * | YT | AB | NT/NUTable 11 - Footnote † | SK | MB | ONTable 11 - Footnote ‡ | QCTable 11 - Footnote § | NB | NS | PETable 11 - Footnote ¶ | NLTable 11 - Footnote ‖ | ||||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Table 11 - Footnote ** | ||
MSM | n/a | 2,899 | 0 | 2 | 16.7 | 993 | 61.7 | 7 | 33.3 | 106 | 25.2 | 152 | 52.2 | 5,392 | 72.3 | 3,798 | 64.2 | 100 | 54.6 | 243 | 67.5 | 16 | 84.2 | 42 | 46.7 | 13,750 | 83.9 |
MSM/IDU | n/a | 276 | 0 | 1 | 8.3 | 32 | 2 | 1 | 4.8 | 17 | 4 | 10 | 3.4 | 294 | 3.9 | 283 | 4.8 | 10 | 5.5 | 12 | 3.3 | 0 | 0 | 2 | 2.2 | 938 | 5.7 |
IDU | n/a | 864 | 0 | 6 | 50 | 191 | 11.9 | 2 | 9.5 | 187 | 44.4 | 35 | 12 | 360 | 4.8 | 461 | 7.8 | 11 | 6 | 25 | 6.9 | 0 | 0 | 4 | 4.4 | 2,146 | 13.1 |
Blood/blood products | Recipient of blood/clotting factor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Recipient of blood | 73 | 0 | 0 | 0 | 29 | 1.8 | 1 | 4.8 | 4 | 1 | 8 | 2.7 | 163 | 2.2 | 84 | 1.4 | 4 | 2.2 | 10 | 2.8 | 0 | 0 | 4 | 4.4 | 380 | 2.3 | |
Recipient of clotting factor | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 3.6 | 8 | 2.7 | 97 | 1.3 | 86 | 1.5 | 22 | 12 | 8 | 2.2 | 2 | 10.5 | 8 | 8.9 | 254 | 1.6 | |
Heterosexual contact | Origin from an HIV-endemic country | 0 | 0 | 0 | 0 | 85 | 5.3 | 0 | 0 | 9 | 2.1 | 14 | 4.8 | 442 | 5.9 | 690 | 11.7 | 6 | 3.3 | 11 | 3.1 | 1 | 5.3 | 1 | 1.1 | 1,259 | 7.7 |
Sexual contact with a person at risk | 312 | 0 | 3 | 25 | 83 | 5.2 | 6 | 28.6 | 40 | 9.5 | 24 | 8.2 | 481 | 6.4 | 243 | 4.1 | 16 | 8.7 | 31 | 8.6 | 0 | 0 | 22 | 24.4 | 1,261 | 7.7 | |
NIR-Het | 261 | 0 | 0 | 0 | 181 | 11.2 | 2 | 9.5 | 40 | 9.5 | 38 | 13.1 | 166 | 2.2 | 179 | 3 | 13 | 7.1 | 19 | 5.3 | 0 | 0 | 3 | 3.3 | 902 | 5.5 | |
Perinatal transmission | n/a | 18 | 0 | 0 | 0 | 8 | 0.5 | 1 | 4.8 | 1 | 0.2 | 2 | 0.7 | 56 | 0.8 | 90 | 1.5 | 0 | 0 | 1 | 0.3 | 0 | 0 | 4 | 4.4 | 181 | 1.1 |
Occupational exposure | n/a | 2 | 0 | 0 | 0 | 1 | 0.1 | 0 | 0 | 1 | 0.2 | 0 | 0 | 5 | 0.1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0.1 |
Other | n/a | 44 | 0 | 0 | 0 | 7 | 0.4 | 1 | 4.8 | 1 | 0.2 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 56 | 0.3 |
Subtotal | n/a | 4,757 | - | 12 | - | 1,610 | - | 21 | - | 421 | - | 291 | - | 7,458 | - | 5,915 | - | 183 | - | 360 | - | 19 | - | 90 | - | 16,380 | - |
NIR | n/a | 186 | - | 1 | - | 2 | - | 0 | - | 11 | - | 9 | - | 349 | - | 183 | - | 6 | - | 1 | - | 2 | - | 1 | - | 751 | - |
Not reported | n/a | 709 | - | 0 | - | 65 | - | 0 | - | 39 | - | 0 | - | 1,479 | - | 0 | - | 0 | - | 0 | - | 0 | - | 0 | - | 2,292 | - |
Total | n/a | 895 | - | 13 | - | 1,677 | - | 21 | - | 471 | - | 300 | - | 9,286 | - | 6,098 | - | 189 | - | 361 | - | 21 | - | 91 | - | 19,423 | - |
Race/ethnicity | Year of diagnosis | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1979-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | %Table 12 - Footnote ‖ | |
IndigenousTable 12 - Footnote ** | 450 | 3.4 | 37 | 43.5 | 27 | 46.6 | 30 | 42.9 | 29 | 55.8 | 22 | 50 | 595 | 4.4 |
South Asian/West Asian/ArabTable 12 - Footnote †† | 111 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.9 | 0 | 0 | 112 | 0.8 |
AsianTable 12 - Footnote ‡‡ | 202 | 1.5 | 2 | 2.4 | 2 | 3.4 | 2 | 2.9 | 0 | 0 | 3 | 6.8 | 211 | 1.6 |
BlackTable 12 - Footnote §§ | 1,495 | 11.3 | 10 | 11.8 | 5 | 8.6 | 8 | 11.4 | 10 | 19.2 | 6 | 13.6 | 1,534 | 11.3 |
Latin AmericanTable 12 - Footnote ¶¶ | 215 | 1.6 | 0 | 0 | 1 | 1.7 | 0 | 0 | 1 | 1.9 | 0 | 0 | 217 | 1.6 |
White | 10,659 | 80.7 | 36 | 42.4 | 23 | 39.7 | 29 | 41.4 | 11 | 21.2 | 13 | 29.5 | 10,771 | 79.7 |
Other | 80 | 0.6 | 0 | 0 | 0 | 0 | 1 | 1.4 | 0 | 0 | 0 | 0 | 81 | 0.6 |
Subtotal | 13,212 | - | 85 | - | 58 | - | 70 | - | 52 | - | 44 | - | 13,521 | - |
Not reportedTable 12 - Footnote ‖‖ | 9,929 | - | 168 | - | 193 | - | 160 | - | 138 | - | 70 | - | 10,658 | - |
Total | 23,141 | - | 253 | - | 251 | - | 230 | - | 190 | - | 114 | - | 24,179 | - |
Age | Total | |
---|---|---|
n | % | |
Children (< 15 years) | ||
Males | 49 | 51 |
Females | 47 | 49 |
Total | 96 | 0.5 |
Adults (≥ 15 years) | ||
Males | 16,704 | 89.3 |
Females | 1,992 | 10.7 |
Total | 18,696 | 99.5 |
Grand Total | 18,792 | 100 |
Males | 16,753 | 89.1 |
Females | 2,039 | 10.9 |
Year of deathTable 14 - Footnote § | Adults (≥ 15 years) | Children (< 15 years) | Total | |||
---|---|---|---|---|---|---|
Number | Cumulative | Number | Cumulative | Number | Cumulative | |
1987 | 518 | 518 | 6 | 6 | 524 | 524 |
1988 | 655 | 1,173 | 5 | 11 | 660 | 1,184 |
1989 | 845 | 2,018 | 5 | 16 | 850 | 2,034 |
1990 | 978 | 2,996 | 4 | 20 | 982 | 3,016 |
1991 | 1,163 | 4,159 | 7 | 27 | 1,170 | 4,186 |
1992 | 1,350 | 5,509 | 8 | 35 | 1,358 | 5,544 |
1993 | 1,553 | 7,062 | 9 | 44 | 1,562 | 7,106 |
1994 | 1,610 | 8,672 | 18 | 62 | 1,628 | 8,734 |
1995 | 1,750 | 10,422 | 14 | 76 | 1,764 | 10,498 |
1996 | 1,298 | 11,720 | 8 | 84 | 1,306 | 11,804 |
1997 | 621 | 12,341 | 5 | 89 | 626 | 12,430 |
1998 | 484 | 12,825 | 0 | 89 | 484 | 12,914 |
1999 | 430 | 13,255 | 1 | 90 | 431 | 13,345 |
2000 | 509 | 13,764 | 2 | 92 | 511 | 13,856 |
2001 | 435 | 14,199 | 0 | 92 | 435 | 14,291 |
2002 | 404 | 14,603 | 1 | 93 | 405 | 14,696 |
2003 | 440 | 15,043 | 0 | 93 | 440 | 15,136 |
2004 | 419 | 15,462 | 1 | 94 | 420 | 15,556 |
2005 | 466 | 15,928 | 2 | 96 | 468 | 16,024 |
2006 | 428 | 16,356 | 0 | 96 | 428 | 16,452 |
2007 | 422 | 16,778 | 0 | 96 | 422 | 16,874 |
2008 | 407 | 17,185 | 0 | 96 | 407 | 17,281 |
2009 | 355 | 17,540 | 0 | 96 | 355 | 17,636 |
2010 | 336 | 17,876 | 0 | 96 | 336 | 17,972 |
2011 | 306 | 18,182 | 0 | 96 | 306 | 18,278 |
2012 | 276 | 18,458 | 0 | 96 | 276 | 18,554 |
2013 | 241 | 18,699 | 0 | 96 | 241 | 18,795 |
Total | 18,699 | n/a | 96 | n/a | 18,795 | n/a |
Year of deathTable 15 - Footnote § | Adult males (≥ 15 years) | Adult females (≥ 15 years) | Total | |||
---|---|---|---|---|---|---|
Number | Cumulative | Number | Cumulative | Number | Cumulative | |
1987 | 486 | 486 | 32 | 32 | 518 | 518 |
1988 | 611 | 1,097 | 44 | 76 | 655 | 1,173 |
1989 | 793 | 1,890 | 52 | 128 | 845 | 2,018 |
1990 | 934 | 2,824 | 44 | 172 | 978 | 2,996 |
1991 | 1,102 | 3,926 | 61 | 233 | 1,163 | 4,159 |
1992 | 1,284 | 5,210 | 66 | 299 | 1,350 | 5,509 |
1993 | 1,465 | 6,675 | 88 | 387 | 1,553 | 7,062 |
1994 | 1,485 | 8,160 | 125 | 512 | 1,610 | 8,672 |
1995 | 1,628 | 9,788 | 122 | 634 | 1,750 | 10,422 |
1996 | 1,192 | 10,980 | 106 | 740 | 1,298 | 11,720 |
1997 | 550 | 11,530 | 71 | 811 | 621 | 12,341 |
1998 | 414 | 11,944 | 70 | 881 | 484 | 12,825 |
1999 | 364 | 12,308 | 66 | 947 | 430 | 13,255 |
2000 | 428 | 12,736 | 81 | 1,028 | 509 | 13,764 |
2001 | 369 | 13,105 | 66 | 1,094 | 435 | 14,199 |
2002 | 343 | 13,448 | 61 | 1,155 | 404 | 14,603 |
2003 | 373 | 13,821 | 67 | 1,222 | 440 | 15,043 |
2004 | 344 | 14,165 | 75 | 1,297 | 419 | 15,462 |
2005 | 369 | 14,534 | 97 | 1,394 | 466 | 15,928 |
2006 | 346 | 14,880 | 82 | 1,476 | 428 | 16,356 |
2007 | 339 | 15,219 | 83 | 1,559 | 422 | 16,778 |
2008 | 313 | 15,532 | 94 | 1,653 | 407 | 17,185 |
2009 | 285 | 15,817 | 70 | 1,723 | 355 | 17,540 |
2010 | 263 | 16,080 | 73 | 1,796 | 336 | 17,876 |
2011 | 231 | 16,311 | 75 | 1,871 | 306 | 18,182 |
2012 | 206 | 16,517 | 70 | 1,941 | 276 | 18,458 |
2013 | 189 | 16,706 | 52 | 1,993 | 241 | 18,699 |
Total | 16,706 | n/a | 1,993 | n/a | 18,699 | n/a |
Country | Cumulative number to 2015Table 16 - Footnote † | Number of reported 2015 | All ages rate per 100,000 population for 2015 |
---|---|---|---|
North America and Australia | |||
Canada | 24,065 | 190 | NR |
United StatesTable 16 - Footnote ‡ | 1,216,917 | 18,303 | 5.7 |
AustraliaTable 16 - Footnote § | NR | NR | NR |
Western EuropeTable 16 - Footnote ¶ | |||
Austria | 3,035 | 70 | 0.8 |
Andorra | 12 | 3 | 4.3 |
Belgium | 4,435 | NR | NR |
Denmark | 2,936 | 40 | 0.7 |
Finland | 654 | 18 | 0.3 |
France | 70,468 | 388 | 0.6 |
Germany | 30,779 | 157 | 0.2 |
Greece | 3,801 | 119 | 1.1 |
Iceland | 67 | 0 | 0 |
Ireland | 1,226 | 29 | 0.6 |
Israel | 1,579 | 36 | 0.4 |
Italy | 68,116 | 789 | 1.3 |
Luxembourg | 302 | 8 | 1.4 |
Malta | 109 | 2 | 0.5 |
Netherlands | 6,209 | 160 | 0.9 |
Norway | 1,136 | 22 | 0.4 |
Portugal | 21,177 | 238 | 2.3 |
San Marino | 23 | 0 | 0 |
Spain | 85,647 | 497 | 1.5 |
SwedenTable 16 - Footnote ‖ | 2,172 | NR | NR |
Switzerland | 9,768 | 44 | 0.5 |
United Kingdom | 29,180 | 432 | 0.7 |
Page details
- Date modified: